{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:07:03Z","timestamp":1791594423986,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Pituitary-dependent hypercortisolism (PDH) is one of the most common endocrine disorders in veterinary medicine. However, there are few reports on pituitary tumor apoplexy (PTA) in dogs and no reports on its surgical intervention in veterinary medicine. Accordingly, the appropriate treatment is unknown. Herein, a case of PDH and PTA in a dog treated surgically is described.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A mongrel female dog (spayed; age, 8\u2009years and 8\u2009months; weight, 6.1\u2009kg) with persistently elevated alkaline phosphatase underwent adrenocorticotropic hormone (ACTH) stimulation testing (post-stimulation cortisol: 20.5\u2009\u03bcg\/dL), abdominal ultrasonography (adrenal gland thickness: left, 5.7\u2009mm; right, 8.1\u2009mm), and brain magnetic resonance imaging (MRI) (pituitary-to-brain ratio [PBR], 0.61) at the referral hospital, resulting in a diagnosis of PDH (day 0). On day 9, the dog visited XXXX for the preparation of pituitary surgery to treat PDH. However, on days 10\u201315, the dog developed a loss of energy and appetite, bloody diarrhea, vomiting, and a decreased level of consciousness. However, on day 16, the dog\u2019s condition recovered. A preoperative MRI scan performed on day 52 (the day of surgery) showed apoplexy in the dorsal pituitary region (PBR, 0.68). Based on the PTA findings, the risks of surgery were described to the owner, and approval was obtained. At the time of trans-sphenoidal surgery, a partial pituitary resection was performed with preservation of the PTA area due to adhesions between the PTA area of the right side of the pituitary and surrounding tissues. The resected pituitary tissue was diagnosed as an ACTH-producing adenoma, with necrotic and hemorrhagic findings. As of day 290, endogenous ACTH and cortisol levels did not exceed the reference range.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The acute signs that occurred on days 10\u201315 were most likely caused by PTA. Therefore, when signs similar to those detected in acute hypoadrenocorticism are observed in dogs with PDH, it is necessary to include PTA as a differential diagnosis. Trans-sphenoidal surgery may be effective in PDH-affected dogs that develop PTA, but careful attention should be paid to tissue adhesions secondary to hemorrhage that may occur after PTA.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12917-022-03502-2","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T03:02:59Z","timestamp":1668222179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Adrenocorticotropic hormone-producing pituitary adenoma with pituitary apoplexy treated by surgical decompression: a case report"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1207-8644","authenticated-orcid":false,"given":"Sachiyo","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Soeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Namiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"issue":"6","key":"3502_CR1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jocn.2014.11.023","volume":"22","author":"PC Johnston","year":"2015","unstructured":"Johnston PC, Hamrahian AH, Weil RJ, Kennedy L. Pituitary tumor apoplexy. J Clin Neurosci. 2015;22(6):939\u201344.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"3502_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12020-014-0359-y","volume":"48","author":"WL Bi","year":"2015","unstructured":"Bi WL, Dunn IF, Laws ER Jr. Pituitary apoplexy. Endocrine. 2015;48(1):69\u201375.","journal-title":"Endocrine"},{"issue":"2","key":"3502_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1046\/j.1365-2265.1999.00754.x","volume":"51","author":"HS Randeva","year":"1999","unstructured":"Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol. 1999;51(2):181\u20138.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"3502_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1227\/01.NEU.0000144840.55247.38","volume":"56","author":"PL Semple","year":"2005","unstructured":"Semple PL, Webb MK, de Villiers JC, Laws ER Jr. Pituitary apoplexy. Neurosurgery. 2005;56(1):65\u201372.","journal-title":"Neurosurgery"},{"issue":"4","key":"3502_CR5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/jnnp.71.4.542","volume":"71","author":"V Biousse","year":"2001","unstructured":"Biousse V, Newman NJ, Oyesiku NM. Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry. 2001;71(4):542\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"3502_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1365-2265.2004.02162.x","volume":"61","author":"J Ayuk","year":"2004","unstructured":"Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJ. Acute management of pituitary apoplexy\u2014surgery or conservative management? Clin Endocrinol. 2004;61(6):747\u201352.","journal-title":"Clin Endocrinol"},{"issue":"6","key":"3502_CR7","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1210\/er.2015-1042","volume":"36","author":"C Briet","year":"2015","unstructured":"Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P. Pituitary apoplexy. Endocr Rev. 2015;36(6):622\u201345.","journal-title":"Endocr Rev"},{"issue":"2","key":"3502_CR8","doi-asserted-by":"publisher","first-page":"e001052","DOI":"10.1136\/vetreccr-2019-001052","volume":"8","author":"C Briola","year":"2020","unstructured":"Briola C, Galli G, Menchetti M, Caldin M, Bertolini G. Pituitary tumour apoplexy due to pituitary adenoma in a dog: clinical, 3T MRI and CT features. Vet Rec Case Rep. 2020;8(2):e001052.","journal-title":"Vet Rec Case Rep"},{"issue":"1","key":"3502_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2265.2010.03913.x","volume":"74","author":"S Rajasekaran","year":"2011","unstructured":"Rajasekaran S, Vanderpump M, Baldeweg S, Drake W, Reddy N, Lanyon M, et al. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol. 2011;74(1):9\u201320.","journal-title":"Clin Endocrinol"},{"issue":"11","key":"3502_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1748-5827.2003.tb00110.x","volume":"44","author":"SN Long","year":"2003","unstructured":"Long SN, Michieletto A, Anderson TJ, Williams A, Knottenbelt CM. Suspected pituitary apoplexy in a German shorthaired pointer. J Small Anim Pract. 2003;44(11):497\u2013502.","journal-title":"J Small Anim Pract"},{"issue":"6","key":"3502_CR11","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/j.1939-1676.2007.tb01946.x","volume":"21","author":"G Bertolini","year":"2007","unstructured":"Bertolini G, Rossetti E, Caldin M. Pituitary apoplexy-like disease in 4 dogs. J Vet Intern Med. 2007;21(6):1251\u20137.","journal-title":"J Vet Intern Med"},{"issue":"4","key":"3502_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/vetsci9040191","volume":"9","author":"G Galli","year":"2022","unstructured":"Galli G, Bertolini G, Dalla Serra G, Menchetti M. Suspected pituitary apoplexy: clinical presentation, diagnostic imaging findings and outcome in 19 dogs. Vet Sci. 2022;9(4):191.","journal-title":"Vet Sci"},{"issue":"3","key":"3502_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/vru.12236","volume":"56","author":"SN Soulsby","year":"2015","unstructured":"Soulsby SN, Holland M, Hudson JA, Behrend EN. Ultrasonographic evaluation of adrenal gland size compared to body weight in normal dogs. Vet Radiol Ultrasound. 2015;56(3):317\u201326.","journal-title":"Vet Radiol Ultrasound"},{"issue":"3","key":"3502_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1677\/joe.0.1520387","volume":"152","author":"HS Kooistra","year":"1997","unstructured":"Kooistra HS, Voorhout G, Mol JA, Rijnberk A. Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J Endocrinol. 1997;152(3):387\u201394.","journal-title":"J Endocrinol"},{"issue":"5","key":"3502_CR15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/jsap.12474","volume":"57","author":"A Sato","year":"2016","unstructured":"Sato A, Teshima T, Ishino H, Harada Y, Yogo T, Kanno N, et al. A magnetic resonance imaging-based classification system for indication of trans-sphenoidal hypophysectomy in canine pituitary-dependent hypercortisolism. J Small Anim Pract. 2016;57(5):240\u20136.","journal-title":"J Small Anim Pract"},{"issue":"1","key":"3502_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jvim.16336","volume":"36","author":"S Tanaka","year":"2022","unstructured":"Tanaka S, Suzuki S, Sato A, Teshima T, Mori A, Sako T, et al. Utility of a corticotropin-releasing hormone test to differentiate pituitary-dependent hyperadrenocorticism from cortisol-producing adrenal tumors in dogs. J Vet Intern Med. 2022;36(1):29\u201338.","journal-title":"J Vet Intern Med"},{"issue":"4","key":"3502_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1532-950X.1997.tb01502.x","volume":"26","author":"BP Meij","year":"1997","unstructured":"Meij BP, Voorhout G, Van den Ingh TS, Hazewinkel HA, Van't Verlaat JW. Transsphenoidal hypophysectomy in beagle dogs: evaluation of a microsurgical technique. Vet Surg. 1997;26(4):295\u2013309.","journal-title":"Vet Surg"},{"key":"3502_CR18","first-page":"1","volume":"11","author":"Y Hara","year":"2020","unstructured":"Hara Y. Transsphenoidal surgery in canines: safety, efficacy and patient selection. Vet Med (Auckl). 2020;11:1\u201314.","journal-title":"Vet Med (Auckl)"},{"issue":"3","key":"3502_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1532-950X.1998.tb00123.x","volume":"27","author":"BP Meij","year":"1998","unstructured":"Meij BP, Voorhout G, van den Ingh TS, Hazewinkel HA, Teske E, Rijnberk A. Results of transsphenoidal hypophysectomy in 52 dogs with pituitary-dependent hyperadrenocorticism. Vet Surg. 1998;27(3):246\u201361.","journal-title":"Vet Surg"},{"issue":"1\u20132","key":"3502_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0303-7207(02)00283-6","volume":"197","author":"B Meij","year":"2002","unstructured":"Meij B, Voorhout G, Rijnberk A. Progress in transsphenoidal hypophysectomy for treatment of pituitary-dependent hyperadrenocorticism in dogs and cats. Mol Cell Endocrinol. 2002;197(1\u20132):89\u201396.","journal-title":"Mol Cell Endocrinol"},{"key":"3502_CR21","volume-title":"Canine and feline nephrology and urology","author":"DJ Chew","year":"2011","unstructured":"Chew DJ, DiBartola SP, Schenck P. Canine and feline nephrology and urology. 2nd ed. St. Louis, Missouri: Elsevier Health Sciences; 2011.","edition":"2"},{"key":"3502_CR22","first-page":"13","volume-title":"Clinical endocrinology of dogs and cats. An illustrated text","author":"BP Meij","year":"2010","unstructured":"Meij BP, Kooistra HS, Rijnberk A. Hypothalamus-pituitary system. In: Rijnberk A, Kooistra HS, editors. Clinical endocrinology of dogs and cats. An illustrated text. 2nd ed. Hannover: Schl\u00fctersche; 2010. p. 13\u201344.","edition":"2"},{"issue":"4","key":"3502_CR23","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3171\/foc.2004.16.4.7","volume":"16","author":"M Verrees","year":"2004","unstructured":"Verrees M, Arafah BM, Selman WR. Pituitary tumor apoplexy: characteristics, treatment, and outcomes. Neurosurg Focus. 2004;16(4):E6.","journal-title":"Neurosurg Focus"},{"issue":"3","key":"3502_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11102-005-1050-3","volume":"7","author":"L Sibal","year":"2004","unstructured":"Sibal L, Ball SG, Connolly V, James RA, Kane P, Kelly WF, et al. Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitar. 2004;7(3):157\u201363.","journal-title":"Pituitar"},{"issue":"7","key":"3502_CR25","first-page":"1240","volume":"23","author":"JM Rogg","year":"2002","unstructured":"Rogg JM, Tung GA, Anderson G, Cortez S. Pituitary apoplexy: early detection with diffusion-weighted MR imaging. AJNR Am J Neuroradiol. 2002;23(7):1240\u20135.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"3502_CR26","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/jvim.12192","volume":"27","author":"EN Behrend","year":"2013","unstructured":"Behrend EN, Kooistra HS, Nelson R, Reusch CE, Scott-Moncrieff JC. Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal). J Vet Intern Med. 2013;27(6):1292\u2013304.","journal-title":"J Vet Intern Med"},{"issue":"1\u20132","key":"3502_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1751-0813.2003.tb11413.x","volume":"81","author":"JA Braddock","year":"2003","unstructured":"Braddock JA. Diagnosis of hyperadrenocorticism in the dog. Aust Vet J. 2003;81(1\u20132):25\u20137.","journal-title":"Aust Vet J"},{"issue":"6","key":"3502_CR28","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1111\/jvim.15330","volume":"32","author":"R Nivy","year":"2018","unstructured":"Nivy R, Refsal KR, Ariel E, Kuzi S, Yas-Natan E, Mazaki-Tovi M. The interpretive contribution of the baseline serum cortisol concentration of the ACTH stimulation test in the diagnosis of pituitary dependent hyperadrenocorticism in dogs. J Vet Intern Med. 2018;32(6):1897\u2013902.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"3502_CR29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2460\/javma.1997.211.03.322","volume":"211","author":"CH Van Liew","year":"1997","unstructured":"Van Liew CH, Greco DS, Salman MD. Comparison of results of adrenocorticotropic hormone stimulation and low-dose dexamethasone suppression tests with necropsy findings in dogs: 81 cases (1985-1995). J Am Vet Med Assoc. 1997;211(3):322\u20135.","journal-title":"J Am Vet Med Assoc"},{"issue":"5","key":"3502_CR30","first-page":"506","volume":"182","author":"EC Feldman","year":"1983","unstructured":"Feldman EC. Comparison of ACTH response and dexamethasone suppression as screening tests in canine hyperadrenocorticism. J Am Vet Med Assoc. 1983;182(5):506\u201310.","journal-title":"J Am Vet Med Assoc"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-022-03502-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-022-03502-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-022-03502-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T01:20:13Z","timestamp":1728350413000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-022-03502-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3502"],"URL":"https:\/\/doi.org\/10.1186\/s12917-022-03502-2","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,12]]},"assertion":[{"value":"14 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The owner provided informed consent for treatment in this case.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The owner provided consent for publication of the case details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"397"}}